Hawaii 24/7

The Centers for Disease Control and Prevention (CDC) is aware that pregnant women, parents of young children, and others may have questions about the safety of thimerosal in vaccines against 2009 H1N1 flu. Here is some information to help you in making decisions.

Read the full story

First, it is important to point out that the recall is not safety-related. As part of its quality assurance program, the manufacturer of the nasal spray monovalent 2009 H1N1 flu vaccine, MedImmune, performs routine, ongoing stability testing of the vaccine. Stability testing means measuring the strength (also called potency) of the vaccine over time to […]

Read the full story

The Hawai‘i State Department of Health (DOH) announced that thanks to vaccine supplies gradually catching up with demand, Hawai‘i vaccination providers can now use the 2009 H1N1 nasal spray vaccine (LAIV — live attenuated influenza vaccine) to vaccinate any healthy, nonpregnant persons ages 2 through 49 years old. Vaccination providers were notified of the expanded […]

Read the full story

Vaccination campaigns currently under way to protect populations from pandemic influenza are among the largest in the history of several countries, and numbers are growing daily. Given this scale of vaccine administration, at least some rare adverse reactions, not detectable during even large clinical trials, could occur, underscoring the need for rigorous monitoring of safety. […]

Read the full story

The Hawai‘i State Department of Health (DOH) announced that the inoculation (shot) version of the 2009 H1N1 Influenza vaccine has arrived in Hawai‘i. Last week, Hawai‘i was allocated 6,700 doses of injectable MIV (monovalent inactivated vaccine) by the U.S. Centers for Disease Control and Prevention (CDC).

Read the full story

The U.S. Food and Drug Administration today warned consumers to use extreme care when purchasing any products over the Internet that claim to diagnose, prevent, treat or cure the H1N1 influenza virus. The warning comes after the FDA recently purchased and analyzed several products represented online as Tamiflu (oseltamivir), which may pose risks to patients

Read the full story

MEDIA RELEASE Approval Provides Important Tool to Fight Pandemic The U.S. Food and Drug Administration announced today that it has approved four vaccines against the 2009 H1N1 influenza virus. The vaccines will be distributed nationally after the initial lots become available, which is expected within the next four weeks. “Today’s approval is good news for […]

Read the full story

We are encouraged by reports that are now emerging from various clinical trials of 2009 H1N1 influenza vaccines, conducted by various vaccine manufacturers. We expect additional companies to announce their preliminary trial results shortly. The early data from these trials indicate that 2009 H1N1 influenza vaccines are well tolerated and induce a strong immune response […]

Read the full story